The ornithine decarboxylase gene is a transcriptional target of c-Myc
- PMID: 8356088
- PMCID: PMC47231
- DOI: 10.1073/pnas.90.16.7804
The ornithine decarboxylase gene is a transcriptional target of c-Myc
Abstract
Constitutive c-myc expression suppresses cell cycle arrest, promotes entry into S phase, and results in the growth factor-independent expression of ornithine decarboxylase (ODC; EC 4.1.1.17). The ODC gene contains a conserved repeat of the Myc binding site, CACGTG, in intron 1. In this report, we demonstrate that c-Myc is a potent transactivator of ODC promoter-reporter gene constructs in fibroblasts that requires the CACGTG repeat. These sites conferred Myc responsiveness on heterologous promoter constructs, suggesting that ODC is regulated by Myc at the level of transcription initiation. Analysis of deletion and point mutants of c-myc revealed that domains required for transactivation of the ODC promoter did not include the leucine zipper of the Myc protein. This suggests that Myc may interact with transcription factors other than Max to transactivate the ODC gene.
Similar articles
-
c-Myc and Max transregulate the mouse ornithine decarboxylase promoter through interaction with two downstream CACGTG motifs.Oncogene. 1995 Nov 2;11(9):1721-7. Oncogene. 1995. PMID: 7478599
-
Position and orientation independent transactivation by c-Myc.Cell Mol Biol Res. 1994;40(7-8):699-706. Cell Mol Biol Res. 1994. PMID: 7787888
-
Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression.Cancer Res. 2001 Apr 1;61(7):3045-52. Cancer Res. 2001. PMID: 11306486
-
Ornithine decarboxylase: structure, function and translational regulation.Biochem Soc Trans. 1994 Nov;22(4):846-52. doi: 10.1042/bst0220846. Biochem Soc Trans. 1994. PMID: 7698473 Review. No abstract available.
-
c-myc expression: keep the noise down!Mol Cells. 2005 Oct 31;20(2):157-66. Mol Cells. 2005. PMID: 16267388 Review.
Cited by
-
Increased polyamines alter chromatin and stabilize autoantigens in autoimmune diseases.Front Immunol. 2013 Apr 17;4:91. doi: 10.3389/fimmu.2013.00091. eCollection 2013. Front Immunol. 2013. PMID: 23616785 Free PMC article.
-
Reprogramming neuroblastoma by diet-enhanced polyamine depletion.bioRxiv [Preprint]. 2024 Jan 8:2024.01.07.573662. doi: 10.1101/2024.01.07.573662. bioRxiv. 2024. PMID: 38260457 Free PMC article. Preprint.
-
Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexus.Front Genet. 2015 Feb 16;6:22. doi: 10.3389/fgene.2015.00022. eCollection 2015. Front Genet. 2015. PMID: 25763008 Free PMC article.
-
Polyamine Blocking Therapy Decreases Survival of Tumor-Infiltrating Immunosuppressive Myeloid Cells and Enhances the Antitumor Efficacy of PD-1 Blockade.Mol Cancer Ther. 2020 Oct;19(10):2012-2022. doi: 10.1158/1535-7163.MCT-19-1116. Epub 2020 Aug 3. Mol Cancer Ther. 2020. PMID: 32747421 Free PMC article.
-
Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation.Genes Dev. 2001 Aug 15;15(16):2069-82. doi: 10.1101/gad.906601. Genes Dev. 2001. PMID: 11511539 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials